{
    "clinical_study": {
        "@rank": "131027", 
        "arm_group": {
            "arm_group_label": "Bilateral Surgical Resection of Carotid Bodies", 
            "arm_group_type": "Experimental", 
            "description": "Patients undergoing Bilateral Surgical Resection of Carotid Bodies."
        }, 
        "brief_summary": {
            "textblock": "The primary aim of the study is to determine safety, tolerability and feasibility of\n      bilateral carotid body resection in patients with systolic heart failure and peripheral\n      chemoreceptor hypersensitivity. The secondary aim is to assess potential efficacy of\n      bilateral carotid body resection."
        }, 
        "brief_title": "Bilateral Surgical Resection of Carotid Bodies in Patients With Systolic Heart Failure", 
        "condition": [
            "Systolic Heart Failure", 
            "Peripheral Chemoreceptor Hypersensitivity"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Heart Failure", 
                "Hypersensitivity", 
                "Heart Failure, Systolic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  History of heart failure class II-III according to NYHA within at least 6 months\n             prior to inclusion\n\n          -  Stable clinical state within at least 4 weeks prior to inclusion\n\n          -  Subject >= 18 years old\n\n          -  Left ventricular ejection fraction \u2264 45% evaluated by transthoracic echocardiography\n             (Simpson's method)\n\n          -  Carotid body present in computer cervical angiotomography\n\n          -  History of exacerbated peripheral chemoreceptor sensitivity determined as\n             >0.6L/min/%SpO2\n\n          -  Able and willing to give written informed consent\n\n        Exclusion Criteria:\n\n          -  Unstable angina pectoris, coronary attack, coronary revascularization, exacerbation\n             of heart-failure requiring hospitalization, clinically significant infection, surgery\n             under general anesthesia within 3 months prior to inclusion\n\n          -  History of stroke, transient ischemic attack (TIA), or clinically significant chronic\n             neurological disorder\n\n          -  History of heart transplant\n\n          -  Pregnancy or anticipation of pregnancy\n\n          -  Hemodialysis or peritoneal dialysis patients\n\n          -  Obstructive carotid atherosclerotic disease with >50% stenosis\n\n          -  COPD stage III and IV according to GOLD 2007\n\n          -  Unable to perform the spiroergometric assessment\n\n          -  Any significant anomaly in additional investigation which may increase the risk of\n             study procedure"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 31, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01782677", 
            "org_study_id": "FIM-B"
        }, 
        "intervention": {
            "arm_group_label": "Bilateral Surgical Resection of Carotid Bodies", 
            "intervention_name": "Bilateral Surgical Resection of Carotid Bodies", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 28, 2013", 
        "location": {
            "contact": {
                "last_name": "Piotr Ponikowski, Prof."
            }, 
            "contact_backup": {
                "last_name": "Piotr Niewinski, MD", 
                "phone": "+48717660230"
            }, 
            "facility": {
                "address": {
                    "city": "Wroclaw", 
                    "country": "Poland", 
                    "zip": "50-981"
                }, 
                "name": "Centrum Choro\u0301b Serca - Klinika Kardiologii, 4. Wojskowy Szpital Kliniczny"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Poland"
        }, 
        "number_of_arms": "1", 
        "official_title": "Bilateral Surgical Resection of Carotid Bodies in Patients With Systolic Heart Failure", 
        "overall_contact": {
            "last_name": "Piotr Ponikowski, Prof.", 
            "phone": "+48717660279"
        }, 
        "overall_official": {
            "affiliation": "4. Wojskowy Szpital Kliniczny we Wroclawiu", 
            "last_name": "Piotr Ponikowski, Prof.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Poland: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Change from baseline in peripheral chemosensitivity measured as ventilatory response to hypoxia using transient inhalation of nitrogen at 4 weeks.", 
                "measure": "Peripheral chemosensitivity", 
                "safety_issue": "Yes", 
                "time_frame": "4 weeks"
            }, 
            {
                "description": "Change from baseline in muscle sympathetic nerve activity at 4 weeks.", 
                "measure": "Muscle sympathetic nerve activity", 
                "safety_issue": "Yes", 
                "time_frame": "4 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01782677"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Change from baseline in exercise tolerance (peak oxygen consumption, slope relating minute ventilation to carbon dioxide production, oxygen uptake efficiency slope, time of exercise, 6-minute walking test distance, New York Heart Association Class) at 4 weeks.", 
                "measure": "Exercise tolerance", 
                "safety_issue": "No", 
                "time_frame": "4 weeks"
            }, 
            {
                "description": "Change from baseline in quality of life (Kansas City Cardiomyopathy Questionnaire, visual analog scale) at 4 weeks.", 
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "4 weeks"
            }, 
            {
                "description": "Change from baseline in serum concentration of NT-proBNP at 4 weeks.", 
                "measure": "Serum concentration of NT-proBNP", 
                "safety_issue": "No", 
                "time_frame": "4 weeks"
            }, 
            {
                "description": "Change from baseline in barosensitivity at 4 weeks.", 
                "measure": "Barosensitivity", 
                "safety_issue": "No", 
                "time_frame": "4 weeks"
            }, 
            {
                "description": "Change from baseline in peripheral chemosensitivity measured as ventilatory response to hypoxia using transient inhalation of nitrogen at 8 weeks.", 
                "measure": "Peripheral chemosensitivity", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "Change from baseline in muscle sympathetic nerve activity at 8 weeks.", 
                "measure": "Muscle sympathetic nerve activity", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "Change from baseline in exercise tolerance (peak oxygen consumption, slope relating minute ventilation to carbon dioxide production, oxygen uptake efficiency slope, time of exercise, 6-minute walking test, New York Heart Association Class) at 8 weeks.", 
                "measure": "Exercise tolerance", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "Change from baseline in sleep pattern in PSG (apnoea-hypopnoea index, percentage of central and obstructive episodes, average oxygen saturation, number of arousals, average duration of apnoeic and hypopnoeic episodes) at 8 weeks.", 
                "measure": "Sleep pattern in PSG", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "Change from baseline in quality of life (Kansas City Cardiomyopathy Questionnaire, visual analog scale) at 8 weeks.", 
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "Change from baseline in heart function and morphology (transthoracic echocardiography) at 8 weeks.", 
                "measure": "Heart function and morphology", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "Change from baseline in serum concentration of NT-proBNP at 8 weeks.", 
                "measure": "Serum concentration of NT-proBNP", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "Change from baseline in barosensitivity at 8 weeks.", 
                "measure": "Barosensitivity", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "Change from baseline in arrhythmia burden (24 hour ECG tape) at 8 weeks.", 
                "measure": "Arrhythmia burden", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }
        ], 
        "source": "Noblewell", 
        "sponsors": {
            "collaborator": {
                "agency": "Cibiem, Inc.", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Noblewell", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}